Addleshaw Goddard advises Buenavista Equity Partners on launch

Addleshaw Goddard has advised Buenavista Equity Partners on the structuring and first close of its new healthcare fund, BV Healthcare Growth Innvierte I. The fund has secured investment commitments totaling €100 million, with a target size of up to €150 million.

The fund’s management benefits from the support of Columbus Venture Partners through a joint venture that combines expertise in venture capital, private equity, and the healthcare sector. The investor base includes Spain’s Center for Technological Development and Innovation (CDTI), which has committed up to €58 million through its Innvierte Program.

BV Healthcare Growth Innvierte I focuses on investing in innovative companies, primarily in Spain, working in areas such as pharmaceutical and biotech product development, diagnostic solutions, precision medicine, medical devices, AI & Big Data applications, digital therapies and diagnostics, scale-up industrial production projects, scientific services (CRO, CDMO), and healthcare services.

The legal advisory team from Addleshaw Goddard was led by Isabel Rodríguez, Partner and Head of the Funds Practice in Madrid, supported by Senior Associate Enrique Torné and Associate Nemesio Fernández.

mercedes.galan@lcpublishinggroup.com

SHARE